Biofilm, 10-HOME and Breast Implant Symptoms: What the Research Found

22 Aug 2026 · 1 min
1:01

In this brief presentation, Dr. Robert Whitfield summarizes a Journal of Clinical Investigation study involving 178 participants divided into three groups: 86 individuals with symptoms attributed to breast implant illness (BII), 55 individuals with breast implants but no symptoms, and 37 individuals without implants. The study reported that the symptomatic BII group exhibited greater biofilm abundance, higher levels of the molecule oxaliplatin‑tenheim (10‑HOME), and a higher prevalence of Staphylococcus epidermidis in tissue samples compared with the control groups. Dr. Whitfield emphasizes that these findings are associative, not proof of causation, and invites viewers to a live explanation of the evidence on Thursday, August 27 at 6 p.m. Central across multiple social platforms, followed by a private, free Q&A session on his Dr. Rob Circle platform.

Chapters

More from Robert

0:46
youtube.com

IT'S NOT MOLD

1d ago
40:02
youtube.com

Do You Need a Lift After Explant? Surgeon Explains Scars & Healing

1d ago
0:37
youtube.com

Donor-Derived Adipose Matrix and Breast Lumps

1d ago
0:44
youtube.com

Live Tonight: After Explant Lift, Fat Transfer, or Both?

1d ago
1:14
youtube.com

Why Breast Lift Planning Goes Beyond Photos

2d ago
0:48
youtube.com

Fat Transfer Donor Areas: BodyTite and Morpheus8

2d ago
0:31
youtube.com

Will They Sag After Explant? Three Factors That Matter

3d ago
0:48
youtube.com

Breast Lift vs. Fat Transfer After Explant

3d ago
0:53
youtube.com

Can Shape Be Restored Without Another Implant?

4d ago
0:45
youtube.com

Combined or Staged After Explant?

4d ago
1:12
youtube.com

How Breast Fat Transfer Is Planned

5d ago
See all content